{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:12:19Z","timestamp":1791245539436,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-026-01149-8","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:02:38Z","timestamp":1776243758000},"page":"790-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-135X","authenticated-orcid":false,"given":"Yingqin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-0690","authenticated-orcid":false,"given":"Dongxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxian","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0452-742X","authenticated-orcid":false,"given":"Zaoqu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-5524","authenticated-orcid":false,"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-9239","authenticated-orcid":false,"given":"Xiaoyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-2277","authenticated-orcid":false,"given":"Linhai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-1454","authenticated-orcid":false,"given":"Linglong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7007-2999","authenticated-orcid":false,"given":"Yin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4685-6296","authenticated-orcid":false,"given":"Sha","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-2929","authenticated-orcid":false,"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-9221","authenticated-orcid":false,"given":"Jia-Xing","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-3636","authenticated-orcid":false,"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-6662","authenticated-orcid":false,"given":"Aihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-4019","authenticated-orcid":false,"given":"Fuchu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"1149_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1149_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N. Engl. J. Med. 381, 1124\u20131135 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1200\/JCO.22.00327","volume":"40","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Final overall survival analysis of gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma: a multicenter, randomized phase III trial. J. Clin. Oncol. 40, 2420\u20132425 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1149_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s44178-023-00040-1","volume":"2","author":"LL Tang","year":"2023","unstructured":"Tang, L. L. et al. CACA guidelines for holistic integrative management of nasopharyngeal carcinoma. Holist. Integr. Oncol. 2, 24 (2023).","journal-title":"Holist. Integr. Oncol."},{"key":"1149_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell, J. J. et al. NCCN Guidelines\u00ae Insights: head and neck cancers, version 1.2022. J. Natl Compr. Canc. Netw. 20, 224\u2013234 (2022).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"1149_CR6","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S1470-2045(24)00504-7","volume":"25","author":"SL Liu","year":"2024","unstructured":"Liu, S. L. et al. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial. Lancet. Oncol. 25, 1563\u20131575 (2024).","journal-title":"Lancet. Oncol."},{"key":"1149_CR7","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/S0140-6736(24)00594-4","volume":"403","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial. Lancet 403, 2720\u20132731 (2024).","journal-title":"Lancet"},{"key":"1149_CR8","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2025.1132","volume":"333","author":"YL Liang","year":"2025","unstructured":"Liang, Y. L. et al. Adjuvant PD-1 blockade with camrelizumab for nasopharyngeal carcinoma: the DIPPER randomized clinical trial. JAMA 333, 1589\u20131598 (2025).","journal-title":"JAMA"},{"key":"1149_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"K Wong","year":"2021","unstructured":"Wong, K. et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat. Rev. Clin. Oncol. 18, 679\u2013695 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1149_CR10","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1016\/S1470-2045(22)00505-8","volume":"23","author":"VH Lee","year":"2022","unstructured":"Lee, V. H. et al. International recommendations for plasma Epstein\u2013Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic. Lancet Oncol. 23, e544\u2013e551 (2022).","journal-title":"Lancet Oncol."},{"key":"1149_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ccell.2023.04.014","volume":"41","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: a multicenter phase 3 trial (RATIONALE-309). Cancer Cell 41, 1061\u20131072 (2023).","journal-title":"Cancer Cell"},{"key":"1149_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-022-00446-5","volume":"22","author":"DR Mani","year":"2022","unstructured":"Mani, D. R. et al. Cancer proteogenomics: current impact and future prospects. Nat. Rev. Cancer 22, 298\u2013313 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567, 257\u2013261 (2019).","journal-title":"Nature"},{"key":"1149_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","volume":"513","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382\u2013387 (2014).","journal-title":"Nature"},{"key":"1149_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/ng.3006","volume":"46","author":"DC Lin","year":"2014","unstructured":"Lin, D. C. et al. The genomic landscape of nasopharyngeal carcinoma. Nat. Genet. 46, 866\u2013871 (2014).","journal-title":"Nat. Genet."},{"key":"1149_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24348-6","volume":"12","author":"JP Bruce","year":"2021","unstructured":"Bruce, J. P. et al. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-\u03baB activation and immune escape. Nat. Commun. 12, 4193 (2021).","journal-title":"Nat. Commun."},{"key":"1149_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01292-5","volume":"20","author":"YP Chen","year":"2021","unstructured":"Chen, Y. P. et al. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Mol. Cancer 20, 14 (2021).","journal-title":"Mol. Cancer"},{"key":"1149_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejca.2021.12.017","volume":"163","author":"SL Liu","year":"2022","unstructured":"Liu, S. L. et al. Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Eur. J. Cancer 163, 26\u201334 (2022).","journal-title":"Eur. J. Cancer"},{"key":"1149_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100567","volume":"22","author":"Y Fu","year":"2023","unstructured":"Fu, Y. et al. Proteomics profiling reveals the molecular signatures and potential therapeutic targets of human nasopharyngeal carcinoma. Mol. Cell. Proteomics 22, 100567 (2023).","journal-title":"Mol. Cell. Proteomics"},{"key":"1149_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04112-8","volume":"21","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma. J. Transl. Med. 21, 278 (2023).","journal-title":"J. Transl. Med."},{"key":"1149_CR21","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1158\/1541-7786.MCR-17-0134","volume":"15","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. Genomic analysis of nasopharyngeal carcinoma reveals TME-based subtypes. Mol. Cancer Res. 15, 1722\u20131732 (2017).","journal-title":"Mol. Cancer Res."},{"key":"1149_CR22","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s41416-024-02579-w","volume":"130","author":"W Lin","year":"2024","unstructured":"Lin, W. et al. Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma. Br. J. Cancer 130, 1176\u20131186 (2024).","journal-title":"Br. J. Cancer"},{"key":"1149_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/jnci\/djaa100","volume":"113","author":"Y Lei","year":"2021","unstructured":"Lei, Y. et al. A gene-expression predictor for efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. J. Natl Cancer Inst. 113, 471\u2013480 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"1149_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.annonc.2019.12.004","volume":"31","author":"H Zhai","year":"2020","unstructured":"Zhai, H. et al. Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma. Ann. Oncol. 31, 169\u2013170 (2020).","journal-title":"Ann. Oncol."},{"key":"1149_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1149_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","volume":"9","author":"S Chen","year":"2024","unstructured":"Chen, S., Zhu, H. & Jounaidi, Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal Transduct. Target. Ther. 9, 302 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1149_CR27","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41590-024-02074-7","volume":"26","author":"J Shen","year":"2025","unstructured":"Shen, J. et al. Short IL-18 generated by caspase-3 cleavage mobilizes NK cells to suppress tumor growth. Nat. Immunol. 26, 416\u2013428 (2025).","journal-title":"Nat. Immunol."},{"key":"1149_CR28","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s43018-023-00570-7","volume":"4","author":"M Boulch","year":"2023","unstructured":"Boulch, M. et al. Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-\u03b3 is a major determinant of CD4+ CAR T-cell antitumor activity. Nat. Cancer 4, 968\u2013983 (2023).","journal-title":"Nat. Cancer"},{"key":"1149_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","volume":"22","author":"AM Gocher","year":"2022","unstructured":"Gocher, A. M. et al. Interferon-\u03b3: teammate or opponent in the tumour microenvironment? Nat. Rev. Immunol. 22, 158\u2013172 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1149_CR30","doi-asserted-by":"crossref","unstructured":"de Sousa-Pereira, P. & Woof, J. M. IgA: structure, function, and developability. Antibodies 8, 57 (2019).","DOI":"10.3390\/antib8040057"},{"key":"1149_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94\u201398 (2015).","journal-title":"Nature"},{"key":"1149_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature24302","volume":"551","author":"S Shalapour","year":"2017","unstructured":"Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340\u2013345 (2017).","journal-title":"Nature"},{"key":"1149_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri2322","volume":"8","author":"A Cerutti","year":"2008","unstructured":"Cerutti, A. The regulation of IgA class switching. Nat. Rev. Immunol. 8, 421\u2013434 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1149_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","volume":"27","author":"C Mauri","year":"2015","unstructured":"Mauri, C. et al. The expanding family of regulatory B cells. Int. Immunol. 27, 479\u2013486 (2015).","journal-title":"Int. Immunol."},{"key":"1149_CR35","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1021\/ci300287t","volume":"52","author":"H Hu","year":"2012","unstructured":"Hu, H. et al. Models for predicting IKKA and IKKB blockade. J. Chem. Inf. Model. 52, 3190\u20133199 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"1149_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1056\/NEJMc1103354","volume":"365","author":"S Takeuchi","year":"2011","unstructured":"Takeuchi, S. et al. NFKBIA deletion in glioblastomas. N. Engl. J. Med. 365, 276\u2013278 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1149_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nri2808","volume":"10","author":"RA Flavell","year":"2010","unstructured":"Flavell, R. A. et al. The polarization of immune cells in the tumour environment by TGF\u03b2. Nat. Rev. Immunol. 10, 554\u2013567 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1149_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350460","volume":"53","author":"F Laudisi","year":"2023","unstructured":"Laudisi, F. et al. TGF-\u03b21 signaling and Smad7 control T-cell responses in health and immune-mediated disorders. Eur. J. Immunol. 53, e2350460 (2023).","journal-title":"Eur. J. Immunol."},{"key":"1149_CR39","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.ccell.2025.06.006","volume":"43","author":"J Qian","year":"2025","unstructured":"Qian, J. et al. A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis. Cancer Cell 43, 1512\u20131529 (2025).","journal-title":"Cancer Cell"},{"key":"1149_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","volume":"24","author":"L Arpinati","year":"2024","unstructured":"Arpinati, L., Carradori, G. & Scherz-Shouval, R. CAF-induced physical constraints controlling T cell state and localization in solid tumours. Nat. Rev. Cancer 24, 676\u2013693 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1149_CR41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard, B., Allard, D., Buisseret, L. & Stagg, J. The adenosine pathway in immuno-oncology. Nat. Rev. Clin. Oncol. 17, 611\u2013629 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1149_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.immuni.2023.05.011","volume":"56","author":"F Bayerl","year":"2023","unstructured":"Bayerl, F. et al. Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses. Immunity 56, 1341\u20131358 (2023).","journal-title":"Immunity"},{"key":"1149_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu, J. et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct. Target. Ther. 10, 268 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1149_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet, R. et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 21, 111 (2020).","journal-title":"Genome Biol."},{"key":"1149_CR45","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","volume":"29","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nat. Med. 29, 1424\u20131436 (2023).","journal-title":"Nat. Med."},{"key":"1149_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52153-4","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Nat. Commun. 15, 7713 (2024).","journal-title":"Nat. Commun."},{"key":"1149_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud, J. L. et al. Tertiary lymphoid structures in anticancer immunity. Nat. Rev. Cancer 24, 629\u2013646 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1149_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35995-2","volume":"14","author":"M Lin","year":"2023","unstructured":"Lin, M. et al. Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance. Nat. Commun. 14, 610 (2023).","journal-title":"Nat. Commun."},{"key":"1149_CR49","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2021.02.055","volume":"184","author":"H Rodriguez","year":"2021","unstructured":"Rodriguez, H., Zenklusen, J. C., Staudt, L. M., Doroshow, J. H. & Lowy, D. R. The next horizon in precision oncology: proteogenomics to inform cancer diagnosis and treatment. Cell 184, 1661\u20131670 (2021).","journal-title":"Cell"},{"key":"1149_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100837","volume":"23","author":"X Shao","year":"2024","unstructured":"Shao, X. et al. ZASP: a highly compatible and sensitive ZnCl2 precipitation-assisted sample preparation method for proteomic analysis. Mol. Cell. Proteomics 23, 100837 (2024).","journal-title":"Mol. Cell. Proteomics"},{"key":"1149_CR51","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.ccell.2024.07.001","volume":"42","author":"J Lv","year":"2024","unstructured":"Lv, J. et al. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: the EP-SEASON study. Cancer Cell 42, 1401\u20131414 (2024).","journal-title":"Cancer Cell"},{"key":"1149_CR52","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5732\/cjc.014.10208","volume":"33","author":"LS Young","year":"2014","unstructured":"Young, L. S. & Dawson, C. W. Epstein\u2013Barr virus and nasopharyngeal carcinoma. Chin. J. Cancer 33, 581\u2013590 (2014).","journal-title":"Chin. J. Cancer"},{"key":"1149_CR53","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2024.01.016","volume":"187","author":"S Chowdhury","year":"2024","unstructured":"Chowdhury, S. et al. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell 187, 1016 (2024).","journal-title":"Cell"},{"key":"1149_CR54","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1149_CR55","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J. et al. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906 (2007).","journal-title":"Nat. Protoc."},{"key":"1149_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41587-019-0344-3","volume":"38","author":"D Ochoa","year":"2020","unstructured":"Ochoa, D. et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 38, 365\u2013373 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1149_CR57","doi-asserted-by":"publisher","first-page":"17974","DOI":"10.1021\/acs.analchem.3c02623","volume":"95","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. RUPE-phospho: rapid ultrasound-assisted peptide-identification-enhanced phosphoproteomics workflow for microscale samples. Anal. Chem. 95, 17974\u201317980 (2023).","journal-title":"Anal. Chem."},{"key":"1149_CR58","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"1149_CR59","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1149_CR60","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li, J. et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell 41, 1152\u20131169 (2023).","journal-title":"Cancer Cell"},{"key":"1149_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D. et al. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"1149_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58675-9","volume":"16","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Multimodal fusion of radio-pathology and proteogenomics identify integrated glioma subtypes with prognostic and therapeutic opportunities. Nat. Commun. 16, 3510 (2025).","journal-title":"Nat. Commun."},{"key":"1149_CR63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2022.12.004","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma. Cancer Cell 41, 181\u2013195 (2023).","journal-title":"Cancer Cell"},{"key":"1149_CR64","doi-asserted-by":"publisher","first-page":"26113","DOI":"10.1103\/PhysRevE.69.026113","volume":"69","author":"ME Newman","year":"2004","unstructured":"Newman, M. E. & Girvan, M. Finding and evaluating community structure in networks. Phys. Rev. E 69, 26113 (2004).","journal-title":"Phys. Rev. E"},{"key":"1149_CR65","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1149_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell\u2013cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"1149_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36062-6","volume":"14","author":"B Ru","year":"2023","unstructured":"Ru, B., Huang, J., Zhang, Y., Aldape, K. & Jiang, P. Estimation of cell lineages in tumors from spatial transcriptomics data. Nat. Commun. 14, 568 (2023).","journal-title":"Nat. Commun."},{"key":"1149_CR68","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1101\/gr.276851.122","volume":"32","author":"Q Liu","year":"2022","unstructured":"Liu, Q., Hsu, C. Y. & Shyr, Y. Scalable and model-free detection of spatial patterns and colocalization. Genome Res. 32, 1736\u20131745 (2022).","journal-title":"Genome Res."},{"key":"1149_CR69","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01149-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:02:05Z","timestamp":1780063325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01149-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01149-8","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}